Cadila Healthcare Share Price Rallies After Receiving FDA Boost – Shares of the drugmaker rose as much as 3.8 percent to Rs 363.10.
The pharmaceutical company received a green signal from the U.S drug regulator Clindamycin Phosphate Topical Solution, used to treat acne, according to its stock exchange filing.
The stock is 19 percent below the Bloomberg consensus one-year price target.
Idea Cellular Swings After A Block Deal
Shares of the telecom operator swung between gains and losses to trade at Rs 52.45.
About 50 lakh shares changed hands in a block deal, Bloomberg data showed. Buyers and sellers were not known immediately.
European Stocks Mixed As Investors Eye Earnings
European equities traded mixed as traders eyed corporate earnings while trade tensions persisted.